Search

everythinglearnresearchcommunity

for

Search:↓

The antibody created from BCC tissues reacts similarly to both BCC and hair follicles, suggesting BCC may come from hair follicle cells.

DNA methylation of miR-365-1 causes hair follicle stem cell death by affecting DAP3.

Targeting ornithine decarboxylase can help prevent skin cancer.

Combining DEB-BACE with chemotherapy is more effective and has fewer side effects than chemotherapy alone for treating unresectable lung squamous cell carcinoma.

Cytokeratin 19 and cytokeratin 15 are key markers for monitoring the quality and self-renewing potential of engineered skin.

Keratin 19 helps identify skin stem cells, with its presence varying by body location, age, and culture stage.

Green tea extract helps prevent cell death and supports cell survival in hair cells exposed to a chemotherapy drug.

The ID2 gene can help distinguish between sensitizers and irritants in skin cells.

PRC1 is essential for proper skin development and stem cell formation by controlling gene activity.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

The role of γδT-cells in causing alopecia areata remains unclear.

DHA derivatives, especially didocosahexaenoin, effectively kill prostate cancer cells and may offer a safer cancer treatment option.

CVP therapy showed moderate success in treating advanced non-Hodgkin's lymphoma, but more intensive treatment is needed for better outcomes.

Cinnamomi cortex may help treat prostate enlargement by reducing related proteins.

BST2 is a key marker for hair loss disease alopecia areata.

Loss of Pten in certain hair follicle stem cells increases skin cancer risk.

CMV infection increases the risk of GvHD after bone marrow transplants.

Donor lymphocyte infusions effectively treated leukemia relapse but caused vitiligo and alopecia areata.

Lokivetmab reduced itching in a dog with skin lymphoma.

CD133+ cells are crucial for hair growth.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

IL-15 helps hair grow longer and stronger by extending the growth phase and reducing cell death.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

Vesiculobullous lesions should be considered part of canine cutaneous epitheliotropic T-cell lymphoma.

Blocking certain proteins on immune cells may help treat alopecia areata.